XOMILADORLIKNI VAQTDAN OLDIN TUSHISHI PROFILAKTIKASI VA DAVOLASh KOMPLEKSIDA MIKRONIZIRLANGAN PROGESTERON QO‘LLANISHI (ADABIYOTLAR TAHLILI)
##article.abstract##
For citation: Ayupova Farida Mirzayevna, Soliyeva Umid Xabibullayevna, Mirodilova Firuza Baxtiyarovna, use of micronized progesterone in the complex of prevention and treatment of miscarriage (review), Journal of reproductive health and uro-nephrology research. 2020, vol. 1, issue 1, pp.
Библиографические ссылки
Клинические рекомендации. Акушерство и гинекология. 4-е изд., перераб. и доп. Под ред. В.Н.Серова, Г.Т.Сухих. М.: ГЭОТАР-Медиа, 2014.
Регистр центров вспомогательных репродуктивных технологий (ВРТ). Отчет за 2004 год. Российская Ассоциация РепродукцииЧеловека (РАРЧ). СПб., 2006.
Краснопольский В.И., Логутова Л.С., Серова О.Ф. и др. Лечение недостаточности лютеиновой фазы у женщин с невынашиванием беременности. Пособие для врачей. М., 2005.
Пестрикова Т.Ю., Юрасова Е.А., Бутко Т.М. Перинатальные потери – резервы снижения. М.: Литтера, 2008.
Серов В.Н., Баранов И.И. Растворы гидроксиэтилированногокрахмала в акушерско-гинекологической практике // РМЖ. 2006. Т. 14, № 1. С. 21–24 [Serov V.N., Baranov I.I. Solutions of hydroxyethylated starch in obstetric-gynecological practice. Russkiymeditsinskiyzhurnal[Russian Medical Journal]. 2006; 14 (1): 21–4. (in Russian)]
Arikan I., Barut A., Harma M., Harma I.M. Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor. GynecolObstet Invest. 2011; 72: 269–73.
Baumbach J., Shi S., Shi L., et al. Inhibition of uterine contractility with various tocolytics with and without progesterone: in vitro studies. Am J Obstet Gynecol. 2012; 206: 254.e1–254.e5.
da Fonseca E.B., Bittar R.E., Carvalho M.H., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Obstet Gynecol. 2003; 188: 419–24.
Fatemi HM, Popovic-Todorovic B, Papanikolaou E et al. An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update 2007;13 (6): 581–90.
Goldenberg R.L., Culhane J.F., IamsJ.D., Romero R. Epidemiology and causes of preterm birth. Lancet. 2008; 371:75–84.
Hassan S., Romero R., Vidyadhari D., et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011; 38:.18–31.
Haas DM, Ramsey PS. Progesteron for preventing miscarriage. Cochrane database of systematic reviews 2008; 2: CD003511; doi: 10.1002/14651858.CD003511.pub2. Review.
Hayes E.J., Paul D.A., Stahl G.E., et al. Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet Gynecol. 2008; 111: 921–6.
Joshi J.T. A Review on Micronization Techniques. J Pharm Sci Technol. 2011; Vol. 3 (7): 651–81.
Navathe R., Berghella V. Tocolysisfor acute preterm labor: where have we been, where are we now, and where are we going? Am J Perinatol. 2016; 33: 229–35.
Nikas G, Reddy N, Winston RML. Implantation correlates highly with the expression of uterine pinopodes in ovum recipients under HRT: a preliminary study. Abstract FR21, IX World Congress in Human Reproduction.Philadelphia, may 29–june 1, 1996.
Norwitz E.R., Robinson J.N., Challis J.R. The control of labor. N Engl J Med. 1999; 341: 660–6.
Raghupathya R, Al-Mutawaa E, Al-Azemib M et al. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J ReprodImmunol 2009; 80 (1–2): 91–9.
Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth (Review). Cochrane Database Syst Rev. 2006; 19: CD004454.
Romero R., et al. Ultrasound ObstetGynecol; 2016 [in press].
Simoncini T, Caruso A, Giretti MS et al. Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide syntesis in human endothelial cells. FertilSteril 2006; 37: 777–87.
Vivat V., Cohen-Tannoudji J., Revelli J.P., et al. Progesterone transcriptionally regulates the beta 2-adrenergic receptor gene in pregnant rat myometrium. J Biol Chem. 1992; 267: 7975–8.
Wahabi HA, Fayed AA, Esmaeil SA et al. Progestogen for treating threatened miscarriage (Review) 2011. The Cochrane Library, Issue 12.
Walch KT, Huber JC. Progesterone for recurrent miscarriage: truth anddeceptions. Best Pract Res ClinObstetGynaecol 2008; 22 (2): 375–89.
Suhag A., Saccone G., Berghella V. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials. Obstet Gynecol. 2015; 213: 479–87.
